Health and Healthcare
577 Articles
Bristol-Myers Squibb Co. (NYSE: BMY) has been a real pest in the world of analyzing options trading activity. There has…
The second half of December is supposed to be when trading volume starts slowing down. That does not look to be the case…
The FDA is routinely criticized for being a poor steward of drug research and pharmaceutical side effects. The agency proved once…
Bristol-Myers Squibb Company (NYSE: BMY) is going to completely separate itself from its holdings in Mead Johnson Nutrition Company (NYSE:…
Reuters: The Ohio Attorney General is suing a number of Wall St. firms. Reuters: GM will start to repay part…
There are a number of ways to rank brand values. One of the most important is the level at which…
These are the top early-bird analyst upgrades and positive research calls which we have seen from Wall Street early this…
These are this Friday morning’s top Wall Street analyst upgrades and positive research calls: AK Steel (AKS) Raised to Buy…
Reuters: The best investment for Chinese companies may be the nation’s own 1.3 billion person home market. Reuters: Japan’s Democrats…
These are this morning’s top pre-market analyst upgrades, downgrades and initiations from Wall Street early this Friday: Barrick Gold (ABX)…
These are this morning’s top day trader alerts and most active in price and volume. We have more detailed analysis…
Diabetes is becoming an epidemic in the U.S. and the Western World. The ties to obesity are often direct, so…
Bristol Myers Inc. (NYSE: BMY) plans to spend $2.4 billion to buy partner Medarex Inc. (Nasdaq: MEDX). It will get…
Reuters: Obama says healthcare reform is essential to the recovery. Reuters: CIT (CIT) bond advisers will push for Chapter 11.…
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line…
Our top personal finance-related articles today. Your wallet will thank you later.